$XBI $134 +2%
Pipeline Updates
$TRIL -5% Will host investor day 4/18. Clinical updates for TTI-622 and TTI-621, updated 2021 milestones and guidance. source
$RDUS +9% Business update, Q1 patient numbers, expected catalyst date on track for H2 2021. source
$AMRN +2% Great Britain approval of Vazkepa. source
$NOVN +20% to present ph 3 data at SID meeting May 3-8, 2021. source
$ZGNX -1% Presented new data at AAN meeting for Fintepla for LGS. source
$ONTX +25% First patient dosed in ph 2 study of rigosertib in SCC. source
Finance Updates
$GKOS +1% Amendment to licensing agreement for topical eyelid delivery platform to include presbyopia. source
$MNOV +1% Received 2 milestone payments totaling $4 million for clinical development of gene therapy product based on AAV. source
$KMPH +1% Receives $10 million from milestone payment for FDA approval of Azstarys from Gurnet Point Capital per license agreement. source
Comments